1	Prednisona	prednisona	NCFS000	C0032952	sustancia	0-10	498(0)_ANS_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
2	10	10	Z	-	-	11-13	498(0)_ANS_clinical_caseMIR	SENT1	-	-
3	mg	mg	NCMN000	-	-	14-16	498(0)_ANS_clinical_caseMIR	SENT1	-	-
4	diarios	diario	AQ0MP0	C0332173	calificador	17-24	498(0)_ANS_clinical_caseMIR	SENT1	-	-
5	v.o.	v.o.	NCFS000	C1527415	calificador	25-29	498(0)_ANS_clinical_caseMIR	SENT1	-	-
6	Lesión	lesión	NCFS000	C0332447#C1313971#C0221198	anomalía_morfológica	0-6	498(0)_ANS_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
7	ósea	óseo	AQ0FS0	C0443157	calificador	7-11	498(0)_ANS_clinical_caseMIR	SENT1	B-Estructura_Corporal	-
8	mandibular	mandibular	AQ0CS0	-	-	12-22	498(0)_ANS_clinical_caseMIR	SENT1	I-Estructura_Corporal	-
9	secundaria	secundario	AQ0FS0	C0175668	calificador	23-33	498(0)_ANS_clinical_caseMIR	SENT1	-	-
10	a	a	SPS00	-	-	34-35	498(0)_ANS_clinical_caseMIR	SENT1	-	-
11	radioterapia	radioterapia	NCFS000	C1522449	-	36-48	498(0)_ANS_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
12	(	(	Fpa	-	-	49-50	498(0)_ANS_clinical_caseMIR	SENT1	-	-
13	osteorradionecrosis	osteorradionecrosis	NC00SC0	C0029461	trastorno	50-69	498(0)_ANS_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
14	)	)	Fpt	-	-	69-70	498(0)_ANS_clinical_caseMIR	SENT1	-	-
15	.	.	Fp	-	-	70-71	498(0)_ANS_clinical_caseMIR	SENT1	-	-

